GlassScriptPhysician profile
Gregory Paul Cook
NPI 1528064904
$3,785.29
in general payments reported to CMS, 2019-2025
32 companies · $540 in 2025
The $540 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $453 · 2021: $254 · 2022: $1,320 · 2023: $379 · 2024: $479 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,397.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,393.60 | 2021-2025 | Urolift |
| Astellas Pharma US INC | $770.96 | 2019-2025 | Veozah, Xtandi |
| Sumitomo Pharma America, INC. | $312.96 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $204.93 | 2021-2025 | Lupron Depot |
| Neotract INC. | $100.03 | 2019-2020 | |
| Myovant Sciences INC. | $95.22 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $90.93 | 2020 | |
| Dendreon Pharmaceuticals LLC | $90.74 | 2019-2025 | Provenge |
| Endo Pharmaceuticals INC. | $78.24 | 2019-2020 | |
| Blue Earth Diagnostics | $78.05 | 2020-2024 | |
| Immunitybio, INC. | $74.48 | 2025 | |
| Procept Biorobotics Corporation | $71.10 | 2021-2025 | Aquabeam System |
| Convatec INC. | $57.82 | 2024 | |
| Merck Sharp & Dohme LLC | $36.44 | 2019-2023 | Lynparza, Keytruda |
| Ferring Pharmaceuticals INC. | $29.45 | 2024 | Adstiladrin |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $29.45 | 2022 | |
| 180 Medical, INC. | $27.22 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $25.99 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $23.83 | 2022 | |
| Abc Home Medical Supply, INC. | $21.19 | 2024 | |
| Urogen Pharma, INC. | $21.08 | 2022 | |
| Myriad Genetic Laboratories, INC. | $20.49 | 2025 | Prolaris |
| Olympus America INC. | $17.47 | 2024 | Itind System |
| Janssen Biotech, INC. | $17.00 | 2025 | Erleada |
| Tolmar, INC. | $16.30 | 2024 | |
| Medtronic, INC. | $15.71 | 2022 | |
| Laborie Medical Technologies Corp. | $14.54 | 2023 | |
| Boston Scientific Corporation | $14.26 | 2019 | |
| Richard Wolf Medical Instruments Corp. | $14.00 | 2019 | |
| Photocure INC | $13.50 | 2024 | Cysview |
| Hitachi Healthcare Americas Corp. | $4.57 | 2019 | |
| Clarus Therapeutics INC. | $3.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.